Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Abnormal production of the TNF-homologue APRIL increases the proliferation of human malignant glioblastoma cell lines via a specific receptor

Abstract

A proliferation-inducing ligand (APRIL) of the tumour necrosis factor (TNF) family is produced in small amounts in many tissues and more abundantly in tumours. APRIL has been reported to promote cell growth in vivo and in vitro. It was recently shown that the production of APRIL in some glioblastoma cell lines does not lead to an increase in cell growth. In this study, we investigated the production of APRIL and its ability to increase the proliferation of eight human glioblastoma cell lines. We found that APRIL was produced in the eight human glioblastoma cell lines tested but not in the normal embryonic astrocyte counterparts of glioblastomas. Flow cytometry demonstrated the presence of a specific APRIL-binding receptor on the cell surface in all the glioblastoma cell lines tested. This receptor was also present on normal embryonic and adult astrocytes and embryonic neural progenitor cells. Moreover, the addition of recombinant human APRIL resulted in an increase in proliferation rate of normal adult astrocytes and in four of eight cell lines tested. Addition of the soluble recombinant TNF-receptor-homologue B-cell maturation (BCMA) chimeric protein, which binds APRIL, confirmed the involvement of APRIL in the growth of malignant glioblastoma cell lines.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  • Barbero S, Bonavia R, Bajetto R, Porcile C, Pirani P, Ravetti JL, Zona GL, Spaziante R, Florio T and Schettini G . (2003). Cancer Res., 63, 1969–1974.

  • Chamak B and Prochiantz A . (1989). Development, 106, 483–491.

  • Davies LG, Dibner MD and Batley JF . (1986). Basic Methods in Molecular Biology. Elsevier: New York.

    Google Scholar 

  • Goswami S, Gupta A and Sharma SK . (1998). J. Neurochem., 71, 1837–1845.

  • Gravestein LA and Borst J . (1998). Sem. Immunol., 10, 423–434.

  • Gross JA, Johnston J, Mudri S, Enselman R, Dillon SR, Madden K, Xu W, Parrish-Novak J, Foster D, Lofton-Day C, Moore M, Littau A, Grossman A, Haugen H, Foley K, Blumberg H, Harrison K, Kindsvogel W and Clegg CH . (2000). Nature, 404, 995–999.

  • Hahne M, Kataoka T, Schröter M, Hofmann K, Irmler M, Bodmer J-L, Schneider P, Bornand T, Holler N, French LE, Sordat B, Rimoldi D and Tschopp J . (1998). J. Exp. Med., 188, 1185–1190.

  • Hansen MB, Nielsen SE and Berg K . (1989). J. Immunol. Methods, 119, 203–210.

  • Held-Feindt J, Lutjohann B, Ungefroren H, Mehdorn HM and Mentlein R . (2003). J. Neurooncol., 63, 117–127.

  • Kelly K, Manos E, Jensen G, Nadauld L and Jones DA . (2000). Cancer Res., 60, 1021–1027.

  • Laâbi Y, Gras MP, Brouet JC, Berger R, Larsen CJ and Tsapis A . (1994). Nucleic Acids Res., 22, 1147–1154.

  • Laâbi Y, Gras MP, Carbonel F, Brouet JC, Berger R, Larsen CJ and Tsapis A . (1992). EMBO J., 11, 3897–3904.

  • López-Fraga M, Fernández R, Albar JP and Hahne M . (2001). EMBO Rep., 21, 945–951.

  • Madry C, Laâbi Y, Callebaut I, Roussel J, Hatzoglou A, Le Coniat M, Mornon JP, Berger R and Tsapis A . (1998). Int. Immunol., 10, 1693–1702.

  • Marsters SA, Yan M, Pitti RM, Haas PE, Dixit VM and Ashkenazi A . (2000). Curr. Biol., 10, 785–788.

  • Miloux B and Lupker JH . (1994). Gene, 149, 341–344.

  • Rennert P, Schneider P, Cachero TG, Thompson J, Trabach L, Hertig S, Holler N, Qian F, Mullen C, Strauch K, Browning JL, Ambrose C and Tschopp J . (2000). J. Exp. Med., 192, 1677–1683.

  • Ridet J-L, Corti O, Pencalet P, Mahanoun N, Hamon M, Philippon J and Mallet J . (1999). Human Gene Ther., 10, 271–280.

  • Roth W, Wagenknecht B, Klumpp A, Naumann U, Hahne M, Tschopp J and Weller M . (2001). Cell Death Differ., 8, 403–410.

  • Schneider P, MacKay F, Steiner V, Hoofmann K, Bodmer JL, Holler N, Ambrose C, Lawton P, Bixler S, Acha-Orbea H, Valmori D, Romero P, Werner-Favre C, Zubler RH, Browning JL and Tschopp J . (1999). J. Exp. Med., 189, 1747–1756.

  • Shu HB, Hu WH and Johnson H . (1999). J. Leuk. Biol., 65, 680–683.

  • Smith CA, Farrah T and Goodwin RG . (1994). Cell, 76, 959–962.

  • Thompson JS, Bixler SA, Qian F, Vora K, Scott MA, Cachero TG, Hession C, Schneider P, Sizing ID, Mullen C, Strauch K, Zafari M, Benjamin CD, Tschopp J, Browning JL and Ambrose C . (2001). Science, 293, 2108–2111.

  • Thompson JS, Schneider P, Kalled SL, Wang LC, Lefevre EA, Cachero TG, MacKay F, Bixler SA, Zafari M, Liu ZY, Woodcock SA, Qiang F, Batten M, Madry C, Richard Y, Benjamin CD, Browning JL, Tsapis A, Tschopp J and Ambrose C . (2000). J. Exp. Med., 192, 129–135.

  • Wu Y, Bressette D, Carrell JA, Kaufman T, Feng P, Taylor K, Gan Y, Cho YH, Garcia AD, Gollatz E, Dimke D, La Fleur D, Migone TS, Nardelli B, Wei P, Ruben SM, Ullrich SJ, Olsen HS, Kanakaraj P, Moore PA and Baker KP . (2000). J. Biol. Chem., 275, 35478–35485.

  • Xia XZ, Treanor J, Senaldi G, Khare SD, Boone T, Kelley M, Theill LE, Colombero A, Solovnev I, Lee F, McCabe S, Elliott R, Miner K, Hawkins N, Guo J, Stolina M, Yu G, Wang J, Delaney J, Meng SY, Boyle WJ and Hsu H . (2000). J. Exp. Med., 192, 137–144.

  • Yu G, Boone T, Delaney J, Hawkins N, Kelley M, Ramakrishnan M, McCabe S, Qiu WR, Kornuc M, Xia XZ, Guo J, Stolina M, Boyle WJ, Sarosi I, Hsu H, Senaldi G and Theill LE . (2000). Nat. Immunol., 1, 252–256.

Download references

Acknowledgements

We thank Dr Gabriel GRAS (CEA, Fontenay aux Roses, France) and Dr Delpech (Centre H Becquerel, CHU de Rouen, France) for generously providing glioblastoma cell lines and Drs Brigitte Miloux and Jan Lupker (Sanofi Recherche, Labège, France) for generously providing p7055. This work was supported by INSERM (Institut National de la Santé et de la Recherche Médicale) and by ARC (Association de la Recherche contre le Cancer, grant 4204).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Andréas Tsapis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Deshayes, F., Laprée, G., Portier, A. et al. Abnormal production of the TNF-homologue APRIL increases the proliferation of human malignant glioblastoma cell lines via a specific receptor. Oncogene 23, 3005–3012 (2004). https://doi.org/10.1038/sj.onc.1207350

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1207350

Keywords

This article is cited by

Search

Quick links